about
Management of Neuropsychiatric Systemic Lupus Erythematosus: Current Approaches and Future PerspectivesNon-invasive imaging to monitor lupus nephritis and neuropsychiatric systemic lupus erythematosusClinical and experimental studies of potentially pathogenic brain-directed autoantibodies: current knowledge and future directionsAnti-NR2A/B Antibodies and Other Major Molecular Mechanisms in the Pathogenesis of Cognitive Dysfunction in Systemic Lupus ErythematosusBiomarkers for CNS involvement in pediatric lupusA case of neuropsychiatric lupus Erythematosus characterized by the Owl's eye sign: a case reportDisease flare patterns and predictors of systemic lupus erythematosus in a monocentric cohort of 423 Japanese patients during a long-term follow-up: The JUDE study.Rapid aneurysm growth and rupture in systemic lupus erythematosusAutoantibody profiling on human proteome microarray for biomarker discovery in cerebrospinal fluid and sera of neuropsychiatric lupusTNF-like weak inducer of apoptosis promotes blood brain barrier disruption and increases neuronal cell death in MRL/lpr mice.25-Hydroxyvitamin D3 Deficiency Independently Predicts Cognitive Impairment in Patients with Systemic Lupus Erythematosus.Decreased Coupling Between Functional Connectivity Density and Amplitude of Low Frequency Fluctuation in Non-Neuropsychiatric Systemic Lupus Erythematosus: a Resting-Stage Functional MRI Study.Value of multidisciplinary reassessment in attribution of neuropsychiatric events to systemic lupus erythematosus: prospective data from the Leiden NPSLE cohort.Outcomes of neuropsychiatric events in systemic lupus erythematosus based on clinical phenotypes; prospective data from the Leiden NP SLE cohort.Relationship Between Clinical and Immunological Features with Magnetic Resonance Imaging Abnormalities in Female Patients with Neuropsychiatric Systemic Lupus Erythematosus.B cell and/or autoantibody deficiency do not prevent neuropsychiatric disease in murine systemic lupus erythematosusIntegrative neuroscience approach to neuropsychiatric lupusA Comprehensive Rehabilitation Approach in a Patient With Serious Neuropsychiatric Systemic Lupus ErythematosusNeuropsychiatric Systemic Lupus Erythematosus Involvement: Towards a Tailored Approach to Our Patients?Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers.The spectrum of neuropsychiatric lupus in a Black Caribbean population: a report of the Barbados National Lupus Registry.The role of B cells and autoantibodies in neuropsychiatric lupus.The Effects of LW-AFC on the Hippocampal Transcriptome in Senescence-Accelerated Mouse Prone 8 Strain, a Mouse Model of Alzheimer's Disease.Diagnosing and attributing neuropsychiatric events to systemic lupus erythematosus: time to untie the Gordian knot?Structural Brain Network Reorganization in Patients with Neuropsychiatric Systemic Lupus Erythematosus.Cyclophosphamide in combination with glucocorticoids for severe neuropsychiatric systemic lupus erythematosus: a retrospective, observational two-centre study.A critical analysis of the tools to evaluate neuropsychiatric lupus.Aquaporin-4-autoimmunity in patients with systemic lupus erythematosus: A predominantly population-based study.Expression of human T cell immunoglobulin domain and mucin-3 (TIM-3) and TIM-3 ligands in peripheral blood from patients with systemic lupus erythematosus.Effects of sustained i.c.v. infusion of lupus CSF and autoantibodies on behavioral phenotype and neuronal calcium signalingA sudden onset of a pseudo-neurological syndrome after HPV-16/18 AS04-adjuvated vaccine: might it be an autoimmune/inflammatory syndrome induced by adjuvants (ASIA) presenting as a somatoform disorder?The Role of Brain-Reactive Autoantibodies in Brain Pathology and Cognitive Impairment.Clinical features and mortality in Chinese with lupus nephritis and neuropsychiatric lupus: A 124-patient study.Attribution in the assessment of nervous system disease in SLE.Evaluation of blood-brain barrier function by quotient alpha2 macroglobulin and its relationship with interleukin-6 and complement component 3 levels in neuropsychiatric systemic lupus erythematosus.Avoiding diagnostic pitfalls in neuropsychiatric lupus: the importance of attribution.A person-centred approach in medicine to reduce the psychosocial and existential burden of chronic and life-threatening medical illness.Platelets release pathogenic serotonin and return to circulation after immune complex-mediated sequestration.Understanding the Antibody Repertoire in Neuropsychiatric Systemic Lupus Erythematosus and Neuromyelitis Optica Spectrum Disorder: Do They Share Common Targets?CSF-1R inhibition attenuates renal and neuropsychiatric disease in murine lupus.
P2860
Q26774815-8DDAFA52-269A-4AE2-9612-D5E1B10725A9Q26796871-F7D5838D-5B18-4B7B-B706-2F0038D67F3AQ26824216-F05A1F86-0B13-48C4-AEBF-29FD4870EC61Q26996498-AD5E9AFE-58DA-481A-A032-F38C64752C72Q28082493-748FB030-693A-4690-8916-F748969E8250Q32178466-779EE20E-432F-49F9-9CD8-EFB097FBE29AQ33434719-CEC20557-EA9D-421A-959A-DA3900A1BAF1Q35025422-30A285C1-6AC1-44E7-8D24-614C783F1FDCQ35625134-D031C4BE-1E22-45C4-BF0D-643F478D60EAQ35688684-F9B3797D-5F9A-45EF-86B2-52CD38D22A6AQ35861014-0E2AEEDC-1692-4646-ABF0-1D150CF6A23DQ36117913-F2A1F9FD-0AE5-48C6-85F1-57BD7302F240Q36322289-9AF61B36-EBE5-4258-9A36-26841AD3E720Q36341961-38B51913-D524-4EE7-AFA1-95C4F21BA845Q36720077-5EC64E75-32B7-4CB6-8A0E-B5B6A616F988Q36774762-A05235BD-05A3-41A4-9BB2-FC78CA988E57Q37032127-28384E94-6102-481E-B6D9-D170C8DEB8C2Q37235501-78D8671D-9219-4707-861C-BAEA86DBE10FQ37632131-95771E7D-6ED0-4F93-8E42-DEC9803A7DC1Q38247180-25E2B081-4F15-43F9-95F7-D19C9105D4EDQ38831853-DCFB2F61-1DB7-49CB-9260-AAC8076AB3A5Q38889566-DCAE01FC-3F04-402D-A7EC-3BBC1186CA1DQ38949860-78A8C8C4-50F6-450D-9622-BE9A8CF8396CQ38981686-0E0F126A-6FE4-412E-B870-92DD723205C6Q39384471-E71B51CC-6FD9-4242-9E32-DD676371B7D4Q40183545-99B147EF-F57D-41C7-A65D-0E216EC775D2Q40258144-91755B7C-7514-47F8-A5DA-2FB7AFAC2068Q40281523-5A5C0CEC-8CB0-473C-A627-EFDAEC7D1B98Q40660212-42ED2978-15E6-4CE6-A616-E3966A307E55Q41524233-9CA32F80-FB40-4F30-8A79-93497F417CF7Q41666889-40C89385-C42F-4024-9EE7-77DB24419D71Q41684146-C7BE0945-8193-4B7F-9E9E-2C3715E1AEE4Q42019937-54044815-8BFE-4D1E-88BC-D082B9633083Q42579446-CFE7A46B-9D94-4CA0-A01D-D6ADF7E6CFF6Q42695876-A33B6FB2-67D5-422C-9AB9-D4F652139A98Q47566238-628DD6B3-EDC8-410D-8A66-B36F3F5B343BQ47652916-235FA6EB-B9DF-4E86-9D3B-784AA1211CC4Q47828127-040B32E5-731A-4604-ABDE-A09F7E0451E2Q47999882-F73E16CE-A983-4A61-A524-090C952A25D5Q48043458-0A574F3C-03FE-43D5-964B-FA8ADADD2F31
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Diagnosis and management of neuropsychiatric SLE.
@en
type
label
Diagnosis and management of neuropsychiatric SLE.
@en
prefLabel
Diagnosis and management of neuropsychiatric SLE.
@en
P2860
P356
P1476
Diagnosis and management of neuropsychiatric SLE.
@en
P2093
John G Hanly
P2860
P2888
P304
P356
10.1038/NRRHEUM.2014.15
P407
P577
2014-02-11T00:00:00Z
P6179
1002685162